Decitabine
Myelofibrosis
Jacqueline Garcia, MDSmall moleculePhase 2Active
CCC
55/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 73/ 100
Competitive context
48 Active assets in the Myelofibrosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Anti-Thymoglobulin, Rabbit Fred Hutchinson Cancer Center | Phase 2 | BB |
CYCLOSPORIN A City of Hope Medical Center | Phase 2 | B |
Cyclophosphamide City of Hope Medical Center | Phase 3 | B |
Busulphan City of Hope Medical Center | Phase 2 | B |
Fludarabine Center for International Blood and Marrow Transplant Research | Phase 3 | B |
View all 50 →
Same molecule, other indications
Decitabine is also rated in:
acute myeloid leukemia with t(8;21)(q22;q22) translocationDormant
BB
Indicative ·
70 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →